Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.52 |
| ▸ | MTNR1A | P48039 | 4/20 | 0.48 |
| ▸ | MTNR1B | P49286 | 4/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | PAOX | Q6QHF9 | 3/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19309079 | 1.00 | MEN1 (0.56) | MEN1KMT2AMAPK1KDM4EHIF1A | |
| SCHEMBL5157716 | 0.97 | MAPK1 (0.55) | MEN1KMT2AMAPK1KDM4EHIF1A | |
| SCHEMBL15224094 | 0.91 | MEN1 (0.48) | MEN1KMT2AMAPK1KDM4EHIF1A | |
| SCHEMBL22906372 | 0.91 | MEN1 (0.48) | MEN1KMT2AMAPK1KDM4EHIF1A | |
| SCHEMBL6002499 | 0.91 | MEN1 (0.48) | MEN1KMT2AMAPK1KDM4EHIF1A | |
| SCHEMBL12417666 | 0.91 | MEN1 (0.48) | MEN1KMT2AMAPK1KDM4EHIF1A | |
| SCHEMBL21771222 | 0.91 | MEN1 (0.48) | MEN1KMT2AMAPK1KDM4EHIF1A | |
| SCHEMBL22856478 | 0.91 | MEN1 (0.48) | MEN1KMT2AMAPK1KDM4EHIF1A | |
| SCHEMBL22526372 | 0.91 | MEN1 (0.48) | MEN1KMT2AMAPK1KDM4EHIF1A | |
| SCHEMBL21771287 | 0.91 | MEN1 (0.48) | MEN1KMT2AMAPK1KDM4EHIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0762901-B9 | TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING | CIS BIO INT (FR) | 2007-01-17 | — | — | EP | claimed |
| EP-0762901-B1 | TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING | BERLEX INC (US) | 2006-04-19 | — | — | EP | claimed |
| US-20050002861-A1 | Enhanced scintigraphic imaging agents for imaging of infection and inflammation | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2005-01-06 | — | — | US | claimed |
| EP-0775160-B1 | CYCLIC HEXAPEPTIDE SOMATOSTATIN ANALOGUES | DIATIDE INC (US) | 2004-08-18 | — | — | EP | claimed |
| EP-1437145-A1 | Enhanced scintigraphic imaging agents for imaging of infection and inflammation | Schering AG (DE) | 2004-07-14 | — | — | EP | claimed |
| EP-0804481-B1 | SOMATOSTATIN DERIVATIVES AND THEIR RADIOLABELLED PRODUCTS | DIATIDE INC (US) | 2003-04-16 | — | — | EP | claimed |
| US-6241965-B1 | MEDICAL DIAGNOSTIC AND ANTITUMOR AGENTS | DIATIDE, INC. | 2001-06-05 | — | — | US | claimed |
| US-6074627-A | STABLE COMPLEX | DIATIDE, INC. (US) | 2000-06-13 | — | — | US | claimed |
| US-6019958-A | POLYBASIC COMPOUND HAVING A MOLECULAR WEIGHT FROM ABOUT 500 DALTONS TO ABOUT 15,000 DALTONS WITH A TECHNETIUM-99M BINDING MOIETY COVALENTLY LINKED TO THE COMPOUND; AND A POLYSULFATED GLYCAN HAVING A MOLECULAR WEIGHT OF AT LEAST ABOUT 1,000 | DIATIDE, INC. (US) | 2000-02-01 | — | — | US | claimed |
| US-5997844-A | Technetium-99m labeled peptides for imaging | DIATIDE, INC. (US) | 1999-12-07 | — | — | US | claimed |
| EP-0702570-B1 | TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING INFLAMMATION | DIATIDE INC (US) | 1999-08-04 | — | — | EP | claimed |
| US-5932189-A | RADIOTHERAPY, RADIODIAGNOSIS PEPTIDES | DIATECH, INC. (US) | 1999-08-03 | — | — | US | claimed |
| US-5830856-A | RADIOLABELED SCINTIGRAPHIC IMAGING | DIATIDE, INC. (US) | 1998-11-03 | — | — | US | claimed |
| WO-1995003330-A1 | SOMATOSTATIN DERIVATIVES AND THEIR RADIOLABELLED PRODUCTS | DIATECH, INC. (US) | 1995-02-02 | — | — | WO | claimed |
| WO-1995000553-A1 | RADIOLABELED SOMATOSTATIN-DERIVED PEPTIDES FOR IMAGING AND THERAPEUTIC USES | DIATECH, INC. (US) | 1995-01-05 | — | — | WO | claimed |
| US-11809077-B2 | Photoresist compositions and pattern formation methods | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2023-11-07 | — | — | US | disclosed |
| US-20220043342-A1 | PHOTORESIST COMPOSITIONS AND PATTERN FORMATION METHODS | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2022-02-10 | — | — | US | disclosed |
| EP-0775160-A1 | CYCLIC HEXAPEPTIDE SOMATOSTATIN ANALOGUES | DIATECH, INC. (US) | 1997-05-28 | — | — | EP | disclosed |
| WO-1996004308-A1 | CYCLIC HEXAPEPTIDE SOMATOSTATIN ANALOGUES | DIATECH, INC. (US) | 1996-02-15 | — | — | WO | disclosed |
| WO-1995003330-A1 | SOMATOSTATIN DERIVATIVES AND THEIR RADIOLABELLED PRODUCTS | DIATECH, INC. (US) | 1995-02-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050002861-A1 | Enhanced scintigraphic imaging agents for imaging of infection and inflammation | SIGLEC7, CD209, SIGLEC9 | MEN1 2294/4885KMT2A 4203/4885MAPK1 2923/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.